A Glimmer of Hope for the FDA and MDMA?
It's been a rollercoaster ride with the FDA and MDMA. And while the news hasn't been great so far, there
Read More
It's been a rollercoaster ride with the FDA and MDMA. And while the news hasn't been great so far, there
Read More
A new study shows how psychedelics transform the way the brain works, which may answer some of the mysteries around
Read More
Running a ketamine clinic can be costly, especially when it comes to office supplies and medications. Join our GPO and
Read More
Surfing icon Kelly Slater shares his perspective on their transformative potential, the stigma, and the importance of responsible use.
Read More
WSJ reporter Katherine Bindley breaks down the continued mainstreaming of psychedelic drug use in Silicon Valley.
Read More
In the first study of its kind, nearly 600 individuals shared how psychedelics impact intimacy and sexual expression.
Read More
Colorado is on the verge of becoming the first state to regulate ibogaine, a powerful plant derived psychedelic with promising
Read More
PharmaTher has secured FDA approval for its ketamine product KETARx, which is specifically for surgical pain management.
Read More
Twenty four Arizonans living with post traumatic stress disorder will participate in a groundbreaking study next month.
Read More
The compounded GLP-1 market has become fiercely competitive. Most clinics compete on price and speed. Mindful Labs wants to change
Read More